|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang X, Vukovic L, Koh HR, Schulten K and
Myong S: Dynamic profiling of double-stranded RNA binding proteins.
Nucleic Acids Res. 43:7566–7576. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Löhr JM: Weighing in on weight loss in
pancreatic cancer. Nature. 558:526–528. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Froeling F and Tuveson D: Pancreatic
cancer foiled by a switch of tumour subtype. Nature. 557:500–501.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cao J, Yang JC, Ramachandran V, Arumugam
T, Deng DF, Li ZS, Xu LM and Logsdon CD: TM4SF1 regulates
pancreatic cancer migration and invasion in vitro and in vivo. Cell
Physiol Biochem. 39:740–750. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pommier A, Anaparthy N, Memos N, Kelley
ZL, Gouronnec A, Yan R, Auffray C, Albrengues J, Egeblad M,
Iacobuzio-Donahue CA, et al: Unresolved endoplasmic reticulum
stress engenders immune-resistant, latent pancreatic cancer
metastases. Science. 360(pii): eaao49082018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song Z, Feng C, Lu Y, Lin Y and Dong C:
PHGDH is an independent prognosis marker and contributes cell
proliferation, migration and invasion in human pancreatic cancer.
Gene. 642:43–50. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Liang Y and He C: Anticancer
activities and mechanisms of heat-clearing and detoxicating
traditional Chinese herbal medicine. Chin Med. 12:202017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li H, Wang X, Liu Y, Pan D, Wang Y, Yang
N, Xiang L, Cai X and Feng Y: Hepatoprotection and hepatotoxicity
of Heshouwu, a Chinese medicinal herb: Context of the paradoxical
effect. Food Chem Toxicol. 108:407–418. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi X, Chen X, Li X, Lan X, Zhao C, Liu S,
Huang H, Liu N, Liao S, Song W, et al: Gambogic acid induces
apoptosis in imatinib-resistant chronic myeloid leukemia cells via
inducing proteasome inhibition and caspase-dependent Bcr-Abl
downregulation. Clin Cancer Res. 20:151–163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hua H, Zhu Y and Song YH: Ruscogenin
suppressed the hepatocellular carcinoma metastasis via
PI3K/Akt/mTOR signaling pathway. Biomed Pharmacother. 101:115–122.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kou J, Tian Y, Tang Y, Yan J and Yu B:
Antithrombotic activities of aqueous extract from Radix
Ophiopogon japonicus and its two constituents. Biol Pharm
Bull. 29:1267–1270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kou J, Sun Y, Lin Y, Cheng Z, Zheng W, Yu
B and Xu Q: Anti-inflammatory activities of aqueous extract from
Radix Ophiopogon japonicus and its two constituents. Biol
Pharm Bull. 28:1234–1238. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu D and Chen L: Ferroptosis: A novel cell
death form will be a promising therapy target for diseases. Acta
Biochim Biophys Sin (Shanghai). 47:857–859. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma S, Henson ES, Chen Y and Gibson SB:
Ferroptosis is induced following siramesine and lapatinib treatment
of breast cancer cells. Cell Death Dis. 7:e23072016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu J, Song Z, Feng C, Lu Y, Zhou Y, Lin Y
and Dong C: The long non-coding RNA SUMO1P3 facilitates breast
cancer progression by negatively regulating miR-320a. Am J Transl
Res. 9:5594–5602. 2017.PubMed/NCBI
|
|
17
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gkouvatsos K, Papanikolaou G and
Pantopoulos K: Regulation of iron transport and the role of
transferrin. Biochim Biophys Acta. 1820:188–202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ward DM and Kaplan J: Ferroportin-mediated
iron transport: Expression and regulation. Biochim Biophys Acta.
1823:1426–1433. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Han H, Du L, Cao Z, Zhang B and Zhou Q:
Triptonide potently suppresses pancreatic cancer cell-mediated
vasculogenic mimicry by inhibiting expression of VE-cadherin and
chemokine ligand 2 genes. Eur J Pharmacol. 818:593–603. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei WT, Chen H, Ni ZL, Liu HB, Tong HF,
Fan L, Liu A, Qiu MX, Liu DL, Guo HC, et al: Antitumor and
apoptosis-promoting properties of emodin, an anthraquinone
derivative from Rheum officinale Baill, against pancreatic cancer
in mice via inhibition of Akt activation. Int J Oncol.
39:1381–1390. 2011.PubMed/NCBI
|
|
22
|
Friedmann Angeli JP, Schneider M, Proneth
B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch
A, Eggenhofer E, et al: Inactivation of the ferroptosis regulator
Gpx4 triggers acute renal failure in mice. Nat Cell Biol.
16:1180–1191. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang L, Kon N, Li T, Wang SJ, Su T,
Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated
activity during tumour suppression. Nature. 520:57–62. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yagoda N, von Rechenberg M, Zaganjor E,
Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM,
Boniface JJ, et al: RAS-RAF-MEK-dependent oxidative cell death
involving voltage-dependent anion channels. Nature. 447:864–868.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fearnhead HO, Vandenabeele P and Vanden
Berghe T: How do we fit ferroptosis in the family of regulated cell
death? Cell Death Differ. 24:1991–1998. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Z, Ding Y, Wang X, Lu S, Wang C, He
C, Wang L, Piao M, Chi G, Luo Y and Ge P: Pseudolaric acid B
triggers ferroptosis in glioma cells via activation of Nox4 and
inhibition of xCT. Cancer Lett. 428:21–33. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eling N, Reuter L, Hazin J, Hamacher-Brady
A and Brady NR: Identification of artesunate as a specific
activator of ferroptosis in pancreatic cancer cells. Oncoscience.
2:517–532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Roh JL, Kim EH, Jang HJ, Park JY and Shin
D: Induction of ferroptotic cell death for overcoming cisplatin
resistance of head and neck cancer. Cancer Lett. 381:96–103. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Legendre C and Garcion E: Iron metabolism:
A double-edged sword in the resistance of glioblastoma to
therapies. Trends Endocrinol Metab. 26:322–331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dixon SJ, Patel DN, Welsch M, Skouta R,
Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS
and Stockwell BR: Pharmacological inhibition of cystine-glutamate
exchange induces endoplasmic reticulum stress and ferroptosis.
Elife. 3:e025232014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Louandre C, Marcq I, Bouhlal H, Lachaier
E, Godin C, Saidak Z, Francois C, Chatelain D, Debuysscher V,
Barbare JC, et al: The retinoblastoma (Rb) protein regulates
ferroptosis induced by sorafenib in human hepatocellular carcinoma
cells. Cancer Lett. 356:971–977. 2015. View Article : Google Scholar : PubMed/NCBI
|
